Assessment of What Patients and Healthcare Providers Value
"What Do You Value?" A Survey Study Assessing How Patients and Health Care Providers Weigh the Different Components of the Value Equation
3 other identifiers
observational
397
1 country
1
Brief Summary
To assess the importance patients place on each of the attributes of value (i.e., outcomes, quality of life \[QOL\], cost, experience), and how these patients’ views differ depending on the stage of their therapy (pretreatment, preoperative therapy, post-operative, long-term surveillance, recurrence).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jun 2020
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 11, 2020
CompletedFirst Submitted
Initial submission to the registry
July 14, 2020
CompletedFirst Posted
Study publicly available on registry
July 23, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 11, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
August 11, 2022
CompletedAugust 31, 2022
August 1, 2022
2.2 years
July 14, 2020
August 30, 2022
Conditions
Outcome Measures
Primary Outcomes (1)
Importance patients place on each of the attributes of value (i.e., outcomes, quality of life [QOL], cost, experience)
We will calculate the mean rank of patients yielding usable data and its corresponding 95% confidence interval. Patient characteristics and survey items will be summarized using descriptive statistics, including means, standard deviations (SDs), proportions, range, and 95% confidence intervals (CIs), etc.
Survey completion up to 1 year
Secondary Outcomes (2)
Most important attributes of value to healthcare providers
Survey completion up to 1 year
Importance care providers (i.e., physicians, nurses, administrators) place on each of the attributes of value (i.e., outcomes, quality of life [QOL], cost, experience)
Survey completion up to 1 year
Study Arms (1)
Observational (survey administration)
Patients and healthcare providers complete a survey over 10-15 minutes.
Interventions
Eligibility Criteria
Patients with pancreatic adenocarcinoma, pancreatic neuroendocrine malignancy, or gastric adenocarcinoma, and healthcare providers involved in the care of gastric and pancreatic cancer patients at the MD Anderson Cancer Center
You may qualify if:
- Any patient who has been treated, or is anticipated to be treated, for potentially resectable, biopsy-proven pancreatic adenocarcinoma, pancreatic neuroendocrine malignancy, or gastric adenocarcinoma
- Providers involved in the care of gastric and pancreatic cancer patients. Providers will include non-collaborative surgical oncologists, medical oncologists, radiation oncologists, administrators, nurses, mid-level providers
- Able to understand the description of the study and willing to participate
You may not qualify if:
- Inability to read and answer questions in English
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- M.D. Anderson Cancer Centerlead
- National Cancer Institute (NCI)collaborator
Study Sites (1)
M D Anderson Cancer Center
Houston, Texas, 77030, United States
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Matthew H Katz
M.D. Anderson Cancer Center
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 14, 2020
First Posted
July 23, 2020
Study Start
June 11, 2020
Primary Completion
August 11, 2022
Study Completion
August 11, 2022
Last Updated
August 31, 2022
Record last verified: 2022-08